ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 86 filers reported holding ANTHERA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $43,000 | -75.8% | 13,700 | -76.3% | 0.00% | -100.0% |
Q2 2016 | $178,000 | -57.6% | 57,767 | -50.2% | 0.00% | -66.7% |
Q1 2016 | $420,000 | -28.3% | 115,990 | -8.1% | 0.00% | -40.0% |
Q4 2015 | $586,000 | -20.8% | 126,190 | +3.8% | 0.01% | -16.7% |
Q3 2015 | $740,000 | -42.8% | 121,590 | -19.0% | 0.01% | -50.0% |
Q2 2015 | $1,294,000 | +137.4% | 150,100 | +23.1% | 0.01% | +140.0% |
Q1 2015 | $545,000 | – | 121,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 1,900,000 | $16,378,000 | 3.36% |
Hilltop Park Associates LLC | 120,000 | $1,034,000 | 2.05% |
Abingworth LLP | 437,994 | $3,767,000 | 1.71% |
Sio Capital Management, LLC | 238,158 | $2,053,000 | 1.01% |
Rhenman & Partners Asset Management AB | 619,600 | $5,341,000 | 0.64% |
Broadfin Capital, LLC | 1,370,457 | $11,813,000 | 0.64% |
Perceptive Advisors | 1,202,156 | $10,363,000 | 0.62% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 931,257 | $8,027,000 | 0.60% |
WEXFORD CAPITAL LP | 177,500 | $1,530,000 | 0.41% |
Rock Springs Capital Management LP | 470,000 | $4,051,000 | 0.30% |